Asia-Pacific, Competitor News, International

Actu-Real Inc. and Jehangir Clinical Dev Centre announce strategic collaboration to further real-world research

ATLANTA, Feb. 24, 2022 /PRNewswire/ — Actu-Real Inc., a US-based specialized Contract Research Organization (CRO) focused on data analytics and Real-World Evidence (RWE) and Jehangir Clinical Development Centre (JCDC), a pioneering CRO conducting world-class clinical and medical research in India, today announced the signing of a strategic collaboration agreement to further research based…

Collaborations, Competitor News

Ciox Health Partners with Diameter Health to Accelerate Its Digital Network Strategy

ALPHARETTA, Ga. and FARMINGTON, Conn., Feb. 23, 2022 /PRNewswire/ — Ciox Health®, a Datavant company, today announced a partnership with Diameter Health, a data interoperability leader and trusted source for organizations seeking to realize the greatest value from clinical data. The partnership will enhance Ciox’s market-leading reach in data retrieval capabilities using Diameter Health’s Fusion engine, the best-in-class solution to…

Competitor News

EVERSANA™ MANAGEMENT CONSULTING Named a Best Boutique Consulting Firm by Vault

CHICAGO, Feb. 23, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced its strategic management consulting solution, EVERSANA™ MANAGEMENT CONSULTING, has been named to Vault’s 2022 Best Boutique Consulting Firm list. EVERSANA MANAGEMENT CONSULTING is among the top 40 boutique consulting firms across the U.S, according…

COVID-19, Partner and Collaborator News

CDC further expands use of Palantir’s Tiberius platform

FEB 22, 2022 | FEDSCOOP The Centers for Disease Control and Prevention will expand use of its Tiberius platform from COVID-19 vaccine distribution to therapeutics distribution and supply chain resiliency, through a $5.3 million contract with Palantir announced Tuesday. The six-month contract allows CDC to integrate additional datasets leveraging the modular software…

Collaborations, Competitor News, Data Partnership

Neuromod welcomes real-world evidence demonstrating the safety and efficacy of the Lenire device for improving symptoms in tinnitus patients

DUBLIN, Feb. 21, 2022 /PRNewswire/ — Irish medical device company, Neuromod Devices Ltd. (Neuromod), has welcomed the findings of an independent study performed at the German Hearing Center (DHZ) at Hannover Medical School, which found that 85% of tinnitus patients experienced a reduction in their tinnitus symptoms (based on the Tinnitus Handicap…

Competitor News, Oncology, Product Updates

U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for KEYTRUDA® (pembrolizumab) to Identify Patients with Microsatellite Instability-High (MSI-H) Solid Tumors

Foundation Medicine’s tissue-based comprehensive genomic profiling test is now the first and only FDA-approved companion diagnostic to aid in identifying patients with MSI-H solid tumors who may benefit from immunotherapy February 21, 2022 06:57 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that it received approval from the…